BR9816059A - Endocrine neuroimmune regulation device and treatment - Google Patents
Endocrine neuroimmune regulation device and treatmentInfo
- Publication number
- BR9816059A BR9816059A BR9816059-1A BR9816059A BR9816059A BR 9816059 A BR9816059 A BR 9816059A BR 9816059 A BR9816059 A BR 9816059A BR 9816059 A BR9816059 A BR 9816059A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- neuroimmune
- model
- endocrine
- carriers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0618—Psychological treatment
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Developmental Disabilities (AREA)
- Hospice & Palliative Care (AREA)
- Social Psychology (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Radiation-Therapy Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Patente de Invenção: <B>"REGULAçãO ENDóCRINA NEUROIMUNE DISPOSITIVO E TRATAMENTO"<D>. Esta invenção consiste de um método e dispositivo especialmente projetado para tratar disfunção endócrina neuroimune fotoestimulando neurónios pigmentados das áreas orbitais do córtex cerebral com luz filtrada, para alcançar uma modulação do eixo hipotálamo pituitária supra-renal e/ou do eixo da medula óssea do cérebro (ou algum outro eixo). O método de tratamento consiste em colocar as pontas dos portadores de lente do dispositivo consecutivamente em três ou mais locais contíguos de cada teto orbital por 2 a 4 minutos por local, duas vezes por semana, por dois meses e por períodos adicionais conforme exigidos. Os pacientes são tratados em uma posição reclinada (ou sentada) com os olhos fechados. Nenhuma luz é enviada através dos olhos. Este tratamento é usado para hipertensão essencial, faringite crónica, artrite reumática, alergias (especialmente respiratórias), imunodeficiência que surge de qualquer causa, câncer, lupus eritematoso sistêmico, eczema, psoriase, doença da tiróide, síndromes virais e outras patologias envolvendo disfunção endócrina neuroimune. O dispositivo é equipado com (pelo menos) dois portadores de lente, cada um com um filtro transmitindo comprimentos de onda com pico em 350-400 nm e 750-800 nm (ou com outras especificações apropriadas), vidro de quartzo, lente biconvexa de 50 dioptrias (mínimo) e bulbo médico de baixa potência ou outra fonte de luz. No modelo portátil, os portadores são montados em uma cobertura plástica retangular contendo um circuito impresso, pivó para posicionar os portadores, um regulador de saída com uma tela digital para voltagem/mA. A entrada é 6V CC (modelo de bateria), 220V CC (modelo principal) e saída de 0.5-3V CC (variável); 50-300 mA. O modelo de hospital é equipado com circuitos computadorizados incluindo funções craniométricas, densitométricas, e outras funções programáveis.Invention Patent: <B> "NEUROIMUNE ENDOCRINE REGULATION DEVICE AND TREATMENT" <D>. This invention consists of a method and device specially designed to treat neuroimmune endocrine dysfunction by stimulating pigmented neurons in the orbital areas of the cerebral cortex with filtered light, to achieve a modulation of the adrenal pituitary hypothalamic axis and / or the brain bone marrow axis ( or some other axis). The treatment method consists of placing the tips of the lens holders of the device consecutively in three or more contiguous locations on each orbital ceiling for 2 to 4 minutes per location, twice a week, for two months and for additional periods as required. Patients are treated in a reclining (or sitting) position with their eyes closed. No light is sent through the eyes. This treatment is used for essential hypertension, chronic pharyngitis, rheumatic arthritis, allergies (especially respiratory), immunodeficiency arising from any cause, cancer, systemic lupus erythematosus, eczema, psoriasis, thyroid disease, viral syndromes and other pathologies involving neuroimmune endocrine dysfunction . The device is equipped with (at least) two lens carriers, each with a filter transmitting wavelengths peaking at 350-400 nm and 750-800 nm (or with other appropriate specifications), quartz glass, biconvex lens of 50 diopters (minimum) and low-power medical bulb or other light source. In the portable model, the carriers are mounted on a rectangular plastic cover containing a printed circuit, pivot to position the carriers, an output regulator with a digital voltage / mA screen. The input is 6V DC (battery model), 220V DC (main model) and 0.5-3V DC output (variable); 50-300 mA. The hospital model is equipped with computerized circuits including craniometric, densitometric, and other programmable functions.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB1998/001865 WO2000024465A1 (en) | 1998-10-23 | 1998-10-23 | Neuro-immune-endocrine regulating device and treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9816059A true BR9816059A (en) | 2001-07-10 |
Family
ID=11004782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9816059-1A BR9816059A (en) | 1998-10-23 | 1998-10-23 | Endocrine neuroimmune regulation device and treatment |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1123136A1 (en) |
| JP (1) | JP2002528192A (en) |
| KR (1) | KR20010107926A (en) |
| CN (1) | CN1327392A (en) |
| AU (1) | AU1049499A (en) |
| BR (1) | BR9816059A (en) |
| CA (1) | CA2348792A1 (en) |
| EA (1) | EA003414B1 (en) |
| MX (1) | MXPA01004044A (en) |
| WO (1) | WO2000024465A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2550993B1 (en) * | 2011-03-29 | 2014-12-10 | Valkee Oy | Devicefor altering dopamine Level |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4649151A (en) * | 1982-09-27 | 1987-03-10 | Health Research, Inc. | Drugs comprising porphyrins |
| US4649935A (en) * | 1984-05-21 | 1987-03-17 | Symtonic Sa | Method of treating neurovegetative disorders and apparatus therefor |
| CH676671A5 (en) * | 1989-07-03 | 1991-02-28 | Teclas Tecnologie Laser S A | |
| JPH10511005A (en) * | 1990-01-08 | 1998-10-27 | ヘルス リサーチ インコーポレイテッド | Submersible lens fiber optic assembly |
| RU2071795C1 (en) * | 1994-01-31 | 1997-01-20 | Акционерное общество "Научно-производственное акционерное предприятие Алтаймедприбор" | Apparatus for producing physiotherapeutic action on patient |
| RU2074753C1 (en) * | 1994-06-09 | 1997-03-10 | Владимир Михайлович Дрюков | Device for physical therapy |
-
1998
- 1998-10-23 BR BR9816059-1A patent/BR9816059A/en not_active IP Right Cessation
- 1998-10-23 AU AU10494/99A patent/AU1049499A/en not_active Abandoned
- 1998-10-23 CN CN98814367A patent/CN1327392A/en active Pending
- 1998-10-23 CA CA002348792A patent/CA2348792A1/en not_active Abandoned
- 1998-10-23 WO PCT/IB1998/001865 patent/WO2000024465A1/en not_active Application Discontinuation
- 1998-10-23 EP EP98952977A patent/EP1123136A1/en not_active Withdrawn
- 1998-10-23 KR KR1020017005071A patent/KR20010107926A/en not_active Application Discontinuation
- 1998-10-23 EA EA200100463A patent/EA003414B1/en not_active IP Right Cessation
- 1998-10-23 JP JP2000578066A patent/JP2002528192A/en active Pending
- 1998-10-23 MX MXPA01004044A patent/MXPA01004044A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1123136A1 (en) | 2001-08-16 |
| KR20010107926A (en) | 2001-12-07 |
| CN1327392A (en) | 2001-12-19 |
| AU1049499A (en) | 2000-05-15 |
| JP2002528192A (en) | 2002-09-03 |
| CA2348792A1 (en) | 2000-05-04 |
| MXPA01004044A (en) | 2003-03-10 |
| WO2000024465A1 (en) | 2000-05-04 |
| EA003414B1 (en) | 2003-04-24 |
| EA200100463A1 (en) | 2001-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3855909T2 (en) | Device and method for determining and modifying the circadian phase and amplitude | |
| Diffey et al. | Phototoxic reactions to piroxicam, naproxen and tiaprofenic acid | |
| Rome et al. | Psychological response to corticotropin, cortisone, and related steroid substances: psychotic reaction types | |
| CN204106476U (en) | Multifunction pediatric surgical operation platform | |
| Donlon et al. | Rapid" digitalization" of decompensated schizophrenic patients with antipsychotic agents | |
| BR9816059A (en) | Endocrine neuroimmune regulation device and treatment | |
| BR8507220A (en) | SYSTEM AND PROCESS TO CONTROL THE DRUG ELECTRONIC MINISTRATION SCHEME | |
| Kostenbauder et al. | Riboflavin enhancement of bilirubin photocatabolism in vivo | |
| Bernecker et al. | Biological effects of architectural lighting and their associated energy utilization | |
| Bennett | The managed care setting as a framework for clinical practice. | |
| FI91363C (en) | Equipment for regulating the state of alertness | |
| Betrus et al. | Seasonal affective disorder, part I: A review of the neural mechanisms for psychosocial nurses | |
| JPH03297004A (en) | Washbasin and stand | |
| CN218589526U (en) | Phototherapy equipment for treating leucoderma | |
| Latorre Barragán et al. | Impact of Blue Light on Circadian Cycle Functions and Its Possible Alterations. | |
| CN221713223U (en) | High flow humidification therapy device oxygen regulation switch holder | |
| DE3630060A1 (en) | UV irradiation unit | |
| CN206837220U (en) | A kind of adjuvant therapy device of mental disease | |
| PHÚ | USING UVB 311 NM NARROWBAND MEDICAL LAMP FOR THE TREATMENT OF PSORIASIS | |
| Ravindra et al. | Melatonina na patogênese e tratamento do câncer | |
| Smart | Oral Health: Just as Important as Ever | |
| Stein | Some practical considerations in the private practice of psycho-geriatrics. | |
| CN111290130A (en) | Piece viewing device for orthopedic diagnosis | |
| SU36595A1 (en) | Rotary apparatus for medical gymnastics | |
| Malyarov et al. | To the problem of clinic-dynamical indices of ionizing radiation effect on psychotic symptoms in patients with schizophrenia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08E | Application fees: payment of additional fee required [chapter 8.5 patent gazette] |
Free format text: COMPLEMENTAR A 3A ANUIDADES REFERENTE A GUIA 300224900527 E COMPRVAR O RECOLHIMENTO REFERENTE A 6AE 7A ANUIDADES. |
|
| B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1855 DE 25/07/2006 POR TER SIDO APRESENTADA PAPELETA DE ESCLARECIMENTO. |
|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1877 DE 26/12/2006. |